Coherus Oncology (CHRS) FCF Margin (QoQ) (2014 - 2026)
Coherus Oncology (CHRS) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Coherus Oncology | 211.33 Mn | 106.02 Mn | 10.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,625.00 |
| Mar 31, 2026 | -24,987.00 |
| Dec 31, 2025 | 18,011.00 |
| Sep 30, 2025 | -465,996.00 |
| Jun 30, 2025 | 466,145.00 |
| Mar 31, 2025 | -77,191.00 |
| Dec 31, 2024 | 139,467.00 |
| Sep 30, 2024 | -199,339.00 |
| Jun 30, 2024 | -514,299.00 |
| Mar 31, 2024 | 612,583.00 |
| Dec 31, 2023 | 5,865.00 |
| Sep 30, 2023 | -637.00 |
| Jun 30, 2023 | 14,592.00 |
| Mar 31, 2023 | 822.00 |
| Dec 31, 2022 | -13,793.00 |
| Sep 30, 2022 | 199.00 |
| Jun 30, 2022 | 628.00 |
| Mar 31, 2022 | -1,896.00 |
| Dec 31, 2021 | -8,827.00 |
| Sep 30, 2021 | 1,699.00 |